Navigation Links
Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results
Date:9/25/2007

Management rolls out new strategic platform for reducing risk of cancer

drug development

MILAN, Italy, Sept. 26 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTAX) held its 2007 annual shareholders meeting (Annual Meeting) on Tuesday, September 25, 2007 in Milan. The Company conducted the Annual Meeting in Milan since a majority of CTI's shares are held by Italian shareholders. At the 2007 Annual Meeting, shareholders re-elected Mary O. Mundinger, Dr. PH, and Jack W. Singer, M.D., as Class III Directors for a term to expire at the 2009 Annual Meeting. Frederick W. Telling, Ph.D., was elected as a Class II Director for a term expiring at the 2008 Annual Meeting. John H. Bauer was elected and Phillip M. Nudelman, Ph.D., was re-elected as Class I Directors for a term to expire at the 2010 Annual Meeting.

Also approved at the 2007 Annual Meeting were a proposal to approve the Company's 2007 Employee Stock Purchase Plan and reserve 250,000 shares of common stock for issuance under the Plan; a proposal to amend and restate the Company's 2003 Equity Incentive Plan, which was retitled as the 2007 Equity Incentive Plan; and a proposal to ratify Stonefield Josephson as CTI's independent auditor for the years ending December 31, 2006 and 2007.

"I'd like to thank our shareholders who voted or provided proxies for our meeting. I'm happy to report that as a result of focusing on outreach to our Italian shareholders and banks and sharing information with them about the process CTI is required to follow in the United States and under Washington law, of the approximately 27 million shares held in Italy, I believe more than two million of them have been voted dir
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. Speaker announces business members of IT Task Force
3. Doyle announces technology tax credits for Berbee
4. Doyle announces new energy, global warming policies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...cyendpointhasbeenmetforpatientswithadvanced-stage,...v.24/PRNewswire-FirstCall/-AEternaZentarisInc.(NAS...ceuticalcompanyfocusedonendocrinetherapyandoncolog...dywithitstargetedcytotoxicpeptideconjugate,AEZS-10...tendometrialcancer.Inapersonalizedhealthcareapproa...
(Date:11/24/2009)...er24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASD...pany,today,announcedthatithassubmittedaMAAtotheEur...ny,senzymereplacementtherapyindevelopment,forthetr...ng,applicationforvelaglucerasealfathathasbeensubmi...anada. , Basedonaglobalsupplyshortageofthecur...
(Date:11/24/2009)...alif.,Nov.24/PRNewswire-FirstCall/--GenomicHealth,...nomicHealth,sExecutiveChairman,willpresentatthe21s...tyonTuesday,December1,2009at10:00a.m.ET. ,, Toa...sentation,visittheInvestorRelationssectionofGenomi...om .Pleaseconnecttothewebsiteatleast15minutesprior...
(Date:11/24/2009)... Program Connects Customers with Partners Vali...h DNA Genotek Products , ...ek , a leading provider of products for biological... today announced its new global partner program. T... Genotek,s partner community and is designed to he...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...EAPOLIS, May 19 G. Arthur Herbert, a Techne Corpo...s Audit Committee, Executive Compensation Committe...ed today that he is planning to retire at the end ... shareholders reelect Directors on an annual basis...r re-nomination as a Director for fiscal year 2010...
... ALTO, Calif., May 19 Pioneering medical device c...learance from the U.S. Food and Drug Administratio...ice, the ,Signos,. , , (Photo: http://www.newsco...ics has developed a cost-effective device that for... health professionals to use ultrasound in their c...
...t-in-class Oral Therapeutic for IBD with Novel Mod...ChemoCentryx, Inc., today announced that data from...ed Oral Therapy Evaluation in Crohn,s disease Tria...(CCX282-B) in patients with moderate-to-severe Cro...at the upcoming 2009 Digestive Disease Week (DDW) ...
Other Biology Technology:Techne Corporation Announces the Retirement of G. Arthur Herbert, a Member of Its Board of Directors 2Signostics Receives FDA Clearance for World's Smallest Ultrasound Product 2ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 2ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 3ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 4ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 5
(Date:11/24/2009)...ridge, Md. (November 24, 2009) New research on ba...ver ecosystems reveals predictable temporal patter...munities as markers for monitoring climate change ...ek in the Proceedings of the National Academy of ...unities in the six rivers shifted synchronously ov...
(Date:11/23/2009)...Cambridge, Mass. November 23, 2009 Applied mathe... lily ( Hosta lancifolia ), a characteristic long ... packed ripples along the edges. The simple cause ...ulting from bending during differential growthwas ...etching foam ribbons. , Haiyi Liang, a postdocto...
(Date:11/23/2009)...ington, CT Current research suggests that a commo.... The related report by Nichols et al, "Unique Li... Class of TLR2 Ligands Capable of Enhancing Autoim... American Journal of Pathology . , Multiple scl...acks the brain and spinal cord, affects nearly 1 i...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2The cause behind the characteristic shape of a long leaf revealed 2Factors from common human bacteria may trigger multiple sclerosis 2Oil and wildlife dont mix in Ecuadors Eden 9876 1Oil and wildlife dont mix in Ecuadors Eden 9876 2Oil and wildlife dont mix in Ecuadors Eden 9876 3Hospira to Host 2009 Investor Day 56847 1Hospira to Host 2009 Investor Day 56847 2Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 1Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 2Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 3
...A - Topics include: onset of plate tectonics on Ea...tem; cause of the end-Permian mass extinction; Old...ins; an ancient mantle plume and the break-up of R...ng glaciers; monitoring Mt. Etna gas composition a...he PETM. The GSA TODAY science article examines Co...
...cuous species, sexual conflict runs in reverse, re...h in Current Biology, a publication of Cell Press....s who aggressively pursue their mates, while males... conflict holds that males, for whom reproducing i...er hand, females, who must pay a heftier price, ar...
...se is available in Spanish . , How did the rode...sula live six million years ago" The researcher of...answer this question through his doctoral thesis "...the Pliocene of the central section of the Guadix ...r Viseras, of the Dept. of Stratigraphy and Palae...
Other Biology News:December GEOLOGY and GSA TODAY media highlights 2December GEOLOGY and GSA TODAY media highlights 3December GEOLOGY and GSA TODAY media highlights 4December GEOLOGY and GSA TODAY media highlights 5December GEOLOGY and GSA TODAY media highlights 6December GEOLOGY and GSA TODAY media highlights 7December GEOLOGY and GSA TODAY media highlights 8December GEOLOGY and GSA TODAY media highlights 9December GEOLOGY and GSA TODAY media highlights 10In promiscuous antelopes, the 'battle of the sexes' gets flipped 2Rodent fossils allows to determine climate of the Iberian Peninsula 6 million years ago 2
Mouse Serum from CHEMICON
Cotinine ELISA Kit, Single from Bio-Quant Inc.
Immunohistochemistry - Gene Discovery from Paragon BioServices
Protein G EIA Kit from Assay Designs/Stressgen Bioreagents
Biology Products: